ArticleCellular oncology (Dordrecht, Netherlands)2020

BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways.

Yang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.